Xcout Intel
NEURONA THERAPEUTICS INC
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Subscribe to see NEURONA THERAPEUTICS INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NEURONA THERAPEUTICS INC at a glance
NEURONA THERAPEUTICS INC is a biotechnology company headquartered in United States. Its most recent funding round raised $102M in April 2025. Xcout tracks 9 named people at NEURONA THERAPEUTICS INC, including James Stutz (Chief Financial Officer).
NEURONA THERAPEUTICS INC leadership
- James StutzChief Financial Officer
- Cory R. NicholasChief Executive Officer and Co-Founder
- Cory NicholasExecutive Officer
- James StutzExecutive Officer
- Brad MargusDirector
- Erica WhittakerDirector
3 more named people on record for NEURONA THERAPEUTICS INC, with roles, board committees and tenure — see the full roster →
NEURONA THERAPEUTICS INC funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $102M | 13 named | |
| SEC Form D filing | $120M | — | |
| — | $120M | — | |
| SEC Form D filing | $72M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent NEURONA THERAPEUTICS INC news
Investors
NEURONA THERAPEUTICS INC competitors
A few of NEURONA THERAPEUTICS INC's closest competitors — see the full list of competitors and alternatives →
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
Get NEURONA THERAPEUTICS INC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on NEURONA THERAPEUTICS INC in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 9 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access